Education
About Us
Working with TipRanks
Follow Us
Peter Presland Insider Profile
4 Followers
Peter Presland, Director at Redx Pharma, holds 3.40M shares in Oxford BioDynamics (Ticker: GB:OBD), holds 266.23K shares in Redx Pharma (Ticker: GB:REDX). Most recently, Peter Presland Bought ― shares of Oxford BioDynamics on Apr 10, 2025 for an estimated value of 14.95K.
Profitable Transactions
3 out of 4 Profitable Transactions
Average Return
+31.00%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Peter Presland holds in companies
Most Profitable Insider Trade
Stock:
Redx Pharma
(REDX)
(REDX)
Rating:Informative Buy
Date:Jul 01, 2020 - Jul 01, 2021
Return:+144.10%
The most profitable trade made by Peter Presland
Peter Presland's Trading History
Redx Pharma
Dec 22, 2020
―
Informative Buy
15.33K
£39.93K
Oxford BioDynamics
Apr 10, 2025
Director
Informative Buy
14.95K
£16.14K
List of latest transactions for each holding click on a transaction to see Peter Presland's performance on stock
You May Also Like
Peter Presland insider profile FAQ
What is the percentage of profitable transactions made by Peter Presland?
The percentage of profitable transactions made by Peter Presland is 75%.
What is the average return per transaction made by Peter Presland?
The average return per transaction made by Peter Presland is 31.00%.
What stocks does Peter Presland hold?
Peter Presland holds: GB:REDX, GB:OBD stocks.
What was Peter Presland’s latest transaction?
Peter Presland latest transaction was an Informative Buy of 14.95K.
What was Peter Presland's most profitable transaction?
Peter Presland’s most profitable transaction was an Informative Buy of GB:REDX stock on July 1, 2020. The return on the trade was 144.10%.
What is Peter Presland's role in Redx Pharma?
Peter Presland's role in Redx Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.